tiprankstipranks
Trending News
More News >

RenovoRx Stockholders Approve Key Proposals at Annual Meeting

Story Highlights
RenovoRx Stockholders Approve Key Proposals at Annual Meeting

Don’t Miss TipRanks’ Half-Year Sale

RenovoRx ( (RNXT) ) has provided an update.

On June 24, 2025, RenovoRx, Inc. held its annual meeting where stockholders voted on several key proposals. The election of directors resulted in the reappointment of six individuals for a one-year term. Additionally, amendments to the company’s 2021 Omnibus Equity Incentive Plan were approved, increasing the shares reserved for issuance and adjusting the plan’s evergreen provision. The appointment of Frank, Rimerman + Co. LLP as the independent auditor for 2025 was also ratified.

The most recent analyst rating on (RNXT) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on RenovoRx stock, see the RNXT Stock Forecast page.

Spark’s Take on RNXT Stock

According to Spark, TipRanks’ AI Analyst, RNXT is a Neutral.

RenovoRx’s overall stock score reflects significant financial instability with persistent losses and negative cash flows. Despite technical analysis suggesting some short-term upward momentum, the company’s valuation is weakened by a negative P/E ratio and lack of profitability. The absence of earnings call data and corporate events limits further insights into potential improvements, maintaining a cautious outlook on its stock performance.

To see Spark’s full report on RNXT stock, click here.

More about RenovoRx

Average Trading Volume: 159,473

Technical Sentiment Signal: Strong Buy

Current Market Cap: $51.57M

For an in-depth examination of RNXT stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1